I.11
BIOTECHNOLOGY IN CAMEROON
LAW NO. 2003/006 OF 21 APRIL 2003 TO LAY DOWN SAFETY REGULATIONS GOVERNING MODERN BIOTECHNOLOGY IN CAMEROON
The National Assembly deliberated and adopted,
The President of the Republic hereby enacts the law set out below:
Chapter I
GENERAL PROVISIONS
Article 1:
This law shall govern:
(1) The safety, development, use including contained use, manipulation and cross-border movement, including the transit of any genetically modified organism that may negatively affect human and animal health, biodiversity and the environment.
(2) The safeguarding of products thereof that may negatively affect human and animal health, biodiversity and the environment.
Article 2 :
(1) This law and its subsequent regulatory instruments shall not apply to organisms whose genetic material has been modified using traditional reproduction and coupling methods to develop and nurture plants and animals in natural conditions.
(2) Unless the genetically modified organisms are of the same species, this law and its subsequent statutory instruments shall not apply to the cytogenetic production of :
(a) genetically modified plant cells, where the same result may be obtained through the use of traditional cultivation techniques;
(b) animal cells under cultivation, where genetic material was obtained from individuals of the same species and where the cells could have been produced through natural reproduction and the use of the same type of plant and animal cells.
(3) It shall also not be applicable to techniques requiring gene therapy involving genetic mutations or cloning, except where such genetic mutations are used for health reasons using laboratory techniques to repair certain deficiencies.
Article 3 :
(1) The services in charge of bio-safety may prohibit any activity involving genetically modified organisms on the basis of the precautionary principle or new scientific knowledge.
(2) The terms and conditions of such prohibition shall be laid down by regulations.
Article 4 :
The objective of this law shall be to:
1- Ensure safety and ethics in modern biotechnological research and development and lay down the procedure for cross-border movement of genetically modified organisms; 2- Provide a mechanism for assessing, managing, communicating and controlling the risks inherent in the use, release and cross-border movement of genetically modified organisms or those having new traits as a result of modern biotechnological activity that may negatively affect the environment, and by extension the conservation and sustainable use of biological resources. This shall be achieved by taking into consideration the risks to human, animal and plant health and their socio-economic effects and by fully developing the benefits of biotechnology, as opposed to traditional technology.
Chapter II
DEFINITIONS
Article 5 :
(1) Advance informed agreement”:
Consent or authorisation given by the competent national administration, following notification by an applicant and before any intentional release, to an importer or exporter permitting him to carry out cross-border movements of a living modified organism, an organism bearing a new trait or a genetically modified organism or products thereof, within or across the country.
(2) Competent national administration: